The days when children were prescribed drugs clinically tested only on adults are long gone. Legislation introduced by the European Medicines Agency (EMEA) is forcing pharma companies to rethink their drug development processes and adapt accordingly. Commercial pharma organisations have traditionally been reluctant to carry out paediatric trials due to the specialised logistics involved but the potential barriers affecting the approval process can no longer be ignored.

SMi’s 2010 Paediatric Clinical Trials conference offers delegates an unrivalled opportunity to explore the latest developments and regulatory changes in this crucial area. Attend and gain valuable insights from industry professionals with the knowledge and experience to help you refine your own strategy. 

Why should you attend this event?

Hear about the regulatory framework for paediatric trials in the US and EU Learn about the latest drug delivery forms and devices Explore therapeutic area specific issues Discuss ethical issues and the consent process Network with industry associates and discuss experiences

Hear keynote addresses from:

• Klaus Rose, Former Global Head of Paediatrics, Roche Pharmaceuticals
• Philippe Auby, Director, International Clinical Research, Paediatric Neuro-Psychiatry, H. Lundbeck

Our expert speaker line-up also includes:

• Birgit Geoerger, Principal Investigator, Institut Gustave Roussy
• Jane Lamprill, Paediatric Research Consultant and Specialist Medical Writer for Children
• James C. McElnay, Chair of the Clinical and Practice Research Group, School of Pharmacy, Queen's University of Belfast
• Vincent Grek, President, Only For Children Pharmaceuticals
• Pamela Kearns, Senior Lecturer in Paediatric Oncology, Institute for Cancer Studies, University of Birmingham
• Ulrich Granzer, Founder, Granzer Regulatory Consulting & Services
• Hartwig Gajek, Director, Global Clinical and Medical Affairs, Baxter Innovations GmbH
• David McIntosh, Honorary Clinical Senior Lecturer, Imperial College, London
• Alastair Kent, Director, Genetic Interest Group
• Abdelbary Elhissi, Senior Lecturer, School of Pharmacy and Pharmaceutical Sciences, University of Central Lancashire

Who should attend?

Vice Presidents, Directors and Heads from within the pharmaceutical or biotech industry with responsibilities in the following areas:

• Paediatrics
• Research and Development
• Clinical Operations
• Regulatory Affairs
• Medical Affairs
• Quality Assurance
• Patient Monitoring
• Compliance

As well as CRO’s and consultants who want to hear about the latest developments in paediatric research

Venue details

Crowne Plaza St James London 45-51 Buckingham Gate London SW1E 6AF Tel: +44 (0) 207 834 6655 Fax: +44 (0) 207 6307 www.london.crowneplaza.com

Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs.  In the heart of Westminster, it is just a stones throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station.

The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu.  A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.
 
Nearest train stations:
• Victoria Station, 7 minutes’ walk
• Waterloo Station, 10 minutes by car

Underground stations:
• St James’s Park, 5 minutes’ walk (District and Circle lines)
• Victoria Station, 7 minutes' walk (Victoria, District and Circle lines)

SMi discounted rates include Continental Breakfast & VAT
£ 205.63 / Standard room / night for single occupancy
£ 229.13 Executive  room / night for single occupancy

Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.